Measurement of myocardial blood flow with positron emission tomography before and after transmyocardial laser revascularization

Circulation

Volumn 100, Issue 19 SUPPL., 1999, Pages

  Rimoldi, Ornella ^a,c   Burns, Sharon M ^b   Rosen, Stuart D ^a   Wistow, Trevor E ^b   Schofield, Peter M ^b   Taylor, Gordon ^b   Camici, Paolo G ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

^c CNR   (Italy)

Author keywords

Blood flow; Coronary disease; Imaging; Laser; Myocardium; Revascularization

Indexed keywords

DOBUTAMINE; WATER O 15;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARBON DIOXIDE LASER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0345201794     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.100.suppl_2.ii-134     Document Type: Article

References (32)

1. Mirhoseini M, Cayton MM. Revascularization of the heart by laser. J Microsurg. 1981;2:253-260.
2. Mirhoseini M, Fisher JC, Cayton MM. Myocardial revascularization by laser: a clinical report. Lasers Surg Med. 1983;3:241-245.
3. Frazier OH, Cooley DA, Kadipasaoglu KA, Pehlivanoglu S, Lindenmeir M, Barasch E, Conger JL, Wilansky S, Moore WH. Myocardial revascularization with laser: preliminary findings. Circulation. 1995;92(suppl II):II-58-II-65.
4. Cooley DA, Frazier OH, Kadipasaoglu KA, Lindmeier MH, Pehlivanoglu S, Kolff JW, Wilansky S, Moore WH. Transmyocardial laser revascularization: clinical experience with twelve-month follow-up. J Thorac Cardiovasc Surg. 1996;111:791-799.
5. Horvath KA, Mannting F, Cummings N, Shernan SK, Cohn LH. Transmyocardial laser revascularization: operative techniques and clinical results at two years. J Thorac Cardiovasc Surg. 1996;11: 1047-1053.
6. Horvath K, Cohn LH, Cooley DA, Crew JR, Frazier OH, Griffith BP, Kadipasaoglu K, Lansing A, Mannting F, March R, Mirhoseine MR, Smith C. Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg. 1997;113:645-654.
7. Mack CA, Magovern CJ, Hahn RT, Sanborn T, Lanning L, Ko W, Isom OW, Rosengart TK. Channel patency and neovascularization after transmyocardial revascularization using an excimer laser. Circulation. 1997;96(suppl II): II-65-II-69.
8. Kohmoto T, DeRosa CM, Yamomoto N, Fisher PE, Failey P, Smith CR, Burkhoff D. Evidence of vascular growth associated with laser treatment of normal canine myocardium. Ann Thorac Surg. 1998;65:1360-1367.
9. Pelletier M, Giaid A, Sivaraman S, Dorfman J, Li CM, Philip A, Chiu RCJ. Angiogenesis and growth factor expression in a model of transmyocardial laser revascularization. Ann Thorac Surg. 1998;66:12-18.
10. Yamamoto N, Kohmoto T, Gu A, DeRosa C, Smith CR, Burkhoff D. Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization. J Am Coll Cardiol. 1998;31:1426-1433.
11. Kwong KF, Kanellopoulos GK, Nichols JC, Pogwizd SM, Saffitz JE, Schuessler RB, Sundt TM III. Transmyocardial laser treatment denervates canine myocardium. J Thorac Cardiovasc Surg. 1997;114:883-890.
12. Hermansen F, Rosen SD, Fath-Ordoubadi F, Kooner JS, Clark JC, Camici PG, Lammertsma A. Measurement of myocardial blood flow with oxygen-15 labeled water: comparison of different administration protocols. Eur J Nucl Med. 1998;25:751-759.
13. Wallwork J, Schofield PM, Caine N, Sharples L, Buxton M. Health technology assessment: TMR trials and tribulations. Lancet, 1996; 348:1386. Letter.
14. Schofield PM, Sharples LD, Caine N, Burns S, Tait S, Wistow T, Buxton M, Wallwork J. Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial. Lancet. 1999;353: 519-524.
15. Schiller NB, for the Committee of Standards, Subcommittee on Quantification of Two-Dimensional Echocardiograms. Recommendation for quantification of the left ventricle two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;5:358-367.
16. Araujo LI, Lammerstma AA. Rhodes CG, McFalls EO, Iida H, Rechavia E, Galassi A, de Silva R, Jones T, Maseri A. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation. 1991;83:875-888.
17. De Silva R, Camici PG. Role of positron emission tomography in the investigation of human coronary circulatory function. Cardiovasc Res. 1994;28:1595-1612.
18. Kaufmann P, Gnecchi Ruscone T, Rimoldi O, Camici PG. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurement with oxygen-15 labeled water and PET. J Nucl Med. In press.
19. Uren NG, Camici PG, Melin J, Bol A, de Bruyne B, Radvan J, Olivotto J, Rosen SD, Impallomeni M, Wiins W. Effect of aging on myocardial perfusion reserve. J Nucl Med. 1995;36:2032-2036.
20. Choudhury L, Elliott P, Rimoldi O, Ryan M, Lammerstma AA, Boyd H, McKenna WJ, Camici PG. Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment. Basic Res Cardiol. 1999;94:49-59.
21. Hoffman EJ, Huang S-C, Phelps ME. Quantitation in positron emission computed tomography, I: effect of object size. J Comput Assist Tomogr. 1979;3:299-308.
22. Krabatsch T, Tambeur L, Lieback E, Shaper F, Hetzer R. Transmyocardial laser revascularization in the treatment of end-stage coronary artery disease. Ann Thorac Cardiovasc Surg. 1998;4:64-71.
23. Gassler N, Wintzer H-O, Stubbe H-M, Wullbrand A, Helmchen U. Transmyocardial laser revascularization: histological features in human nonresponder myocardium. Circulation. 1997;95:371-375.
24. Sigel JE, Abramovich CM, Lytle BW, Ratliff NB. Transmyocardial laser revascularization: three sequential autopsy cases. J Thorac Cardiovasc Surg. 1998;115:1381-1385.
25. Fleischer KJ, Goldschmidt-Clermont PJ, Fonger JD, Hutchins GM, Hruban RH, Baumgartner WA. One-month histologic response of transmyocardial laser channels with molecular intervention. Ann Thorac Surg. 1996;62:1051-1058.
26. Whittaker P, Rakusan K, Kloner R. Transmural channels can protect ischemic tissue: assessment of long-term myocardial response to laser- and needle-made channels. Circulation. 1996;93:143-152.
27. Kohomoto T, DeRosa C, Yamamoto N, Fisher PE, Failey P, Smith CR, Burkhoff D. Evidence of vascular growth associated with laser treatment of normal canine myocardium. Ann Thorac Surg. 1998;65:1360-1367.
28. Vatner DE, Lavallee M, Amano J, Finizola A, Homey CJ, Vatner SF. Mechanism of supersensitivity to sympathomimetic amines in the chronically denervated heart of conscious dogs. Circ Res. 1985;57:55-64.
29. Severi S, Underwood R, Mohiaddin RH, Boyd HL, Paterni M, Camici PG. Dobutamine stress: effect of regional myocardial blood flow and wall motion. J Am Coll Cardiol. 1995;26:1187-1195.
30. Baliga RR, Rosen SD, Camici PG, Kooner JS. Regional myocardial blood flow redistribution as a cause of postprandial angina pectoris. Circulation. 1998;97:1144-1149.
31. Chilian WM, Ackell PH. Transmural differences in sympathetic coronary constriction during exercise in the presence of a coronary stenosis. Circ Res. 1988;62:216-225.
32. Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary artery stenosis. N Engl J Med. 1994;330:1782-1788.